1. Search Result
Search Result
Results for "

MKK6

" in MedChemExpress (MCE) Product Catalog:

11

Inhibitors & Agonists

2

Natural
Products

6

Recombinant Proteins

10

Antibodies

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-119917
    Gossypetin
    4 Publications Verification

    p38 MAPK MEK Bacterial Infection Cancer
    Gossypetin is a hexahydroxylated flavonoid and is a potent mitogen-activated protein kinase kinase (MKK)3 and MKK6 inhibitor with strongly attenuates the MKK3/6-p38 signaling pathway, has various pharmacological activities, including antioxidant, antibacterial and anticancer activities .
    Gossypetin
  • HY-10542
    GW 5074
    5+ Cited Publications

    Raf Apoptosis Cancer
    GW 5074 is a potent and selective c-Raf inhibitor with IC50 of 9 nM, and has no effect on the activities of JNK1/2/3, MEK1, MKK6/7, CDK1/2, c-Src, p38 MAP, VEGFR2 or c-Fms .
    GW 5074
  • HY-13866
    Ro 31-8220 mesylate
    Maximum Cited Publications
    13 Publications Verification

    Ro 31-8220 methanesulfonate; Bisindolylmaleimide IX mesylate

    PKC JNK Cardiovascular Disease Neurological Disease Cancer
    Ro 31-8220 mesylate is a potent PKC inhibitor, with IC50s of 5, 24, 14, 27, 24 and 23 nM for PKCα, PKCβI, PKCβII, PKCγ, PKCε and rat brain PKC, respectively. Ro 31-8220 also significantly inhibits MAPKAP-K1b, MSK1, S6K1 and GSK3β (IC50s, 3, 8, 15, and 38 nM, respectively), with no effect on MKK3, MKK4, MKK6 and MKK7. Ro 31-8220 mesylate can also inhibit the expression of MKP-1, induce the expression of c-Jun, and activate JNK, and these effects possess pharmacological properties independent of PKC .
    Ro 31-8220 mesylate
  • HY-13866A

    Bisindolylmaleimide IX

    PKC JNK Cardiovascular Disease Neurological Disease
    Ro 31-8220 is a potent PKC inhibitor, with IC50s of 5, 24, 14, 27, 24 and 23 nM for PKCα, PKCβI, PKCβII, PKCγ, PKCε and rat brain PKC, respectively. Ro 31-8220 also significantly inhibits MAPKAP-K1b, MSK1, S6K1 and GSK3β (IC50s, 3, 8, 15, and 38 nM, respectively), with no effect on MKK3, MKK4, MKK6 and MKK7. Ro 31-8220 can also inhibit the expression of MKP-1, induce the expression of c-Jun, and activate JNK, and these effects possess pharmacological properties independent of PKC .
    Ro 31-8220
  • HY-E70759

    p38 MAPK Cancer
    The mitogen-activated protein kinase kinase 6 (MKK6) is one of the upstream activators of p38 MAPK. MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 MAPK-dependent manner. MKK6 SDTD is a mutant of MKK6. MKK6 SDTD Recombinant Human Active Protein Kinase is a recombinant MKK6 SDTD protein that can be used to study MKK6 SDTD-related functions .
    MKK6 SDTD Recombinant Human Active Protein Kinase
  • HY-N11723

    Katenarin

    CCR CXCR p38 MAPK JNK Calcium Channel Infection Metabolic Disease Inflammation/Immunology
    Catenarin, an anthraquinone compound, inhibits CCR5- and CXCR4-mediated chemotaxis. Catenarin reduces the phosphorylation of mitogen-activated protein kinases (p38 and JNK) and their upstream kinases (MKK6 and MKK7), and calcium mobilization. Catenarin shows anti-inflammatory effect and suppresses leukocyte migration in the diabetes. Catenarin exhibits significant inhibitory effects against Gram-positive bacteria. Catenarin prevents type 1 diabetes (T1D) in nonobese diabetic mice [1][2].
    Catenarin
  • HY-10542R

    Reference Standards Raf Apoptosis Cancer
    GW 5074 (Standard) is the analytical standard of GW 5074 (HY-10542). This product is intended for research and analytical applications. GW 5074 is a potent and selective c-Raf inhibitor with IC50 of 9 nM, and has no effect on the activities of JNK1/2/3, MEK1, MKK6/7, CDK1/2, c-Src, p38 MAP, VEGFR2 or c-Fms .
    GW 5074 (Standard)
  • HY-RS17782

    Small Interfering RNA (siRNA) Others

    Map2k6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Map2k6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Map2k6 Mouse Pre-designed siRNA Set A
    Map2k6 Mouse Pre-designed siRNA Set A
  • HY-RS08044

    Small Interfering RNA (siRNA) Others

    MAP2K6 Human Pre-designed siRNA Set A contains three designed siRNAs for MAP2K6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    MAP2K6 Human Pre-designed siRNA Set A
    MAP2K6 Human Pre-designed siRNA Set A
  • HY-13866R

    Ro 31-8220 methanesulfonate (Standard); Bisindolylmaleimide IX mesylate (Standard)

    PKC JNK Reference Standards Cardiovascular Disease Neurological Disease Cancer
    Ro 31-8220 mesylate (Standard) is the analytical standard of Ro 31-8220 mesylate (HY-13866). This product is intended for research and analytical applications. Ro 31-8220 mesylate is a potent PKC inhibitor, with IC50s of 5, 24, 14, 27, 24 and 23 nM for PKCα, PKCβI, PKCβII, PKCγ, PKCε and rat brain PKC, respectively. Ro 31-8220 also significantly inhibits MAPKAP-K1b, MSK1, S6K1 and GSK3β (IC50s, 3, 8, 15, and 38 nM, respectively), with no effect on MKK3, MKK4, MKK6 and MKK7. Ro 31-8220 mesylate can also inhibit the expression of MKP-1, induce the expression of c-Jun, and activate JNK, and these effects possess pharmacological properties independent of PKC .
    Ro 31-8220 mesylate (Standard)
  • HY-RS24249

    Small Interfering RNA (siRNA) Others

    Map2k6 Rat Pre-designed siRNA Set A contains three designed siRNAs for Map2k6 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Map2k6 Rat Pre-designed siRNA Set A
    Map2k6 Rat Pre-designed siRNA Set A

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: